Ravi Amaravadi, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma (NCT04464759) | Ravi Amaravadi, MD | 2020-10-21 |
| The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine) (NCT04329923) | Ravi Amaravadi, MD | 2020-04-09 |
Track Ravi Amaravadi, MD automatically
Every clearance here is in the API, with alerts when new ones post.